Publication | Open Access
Efficacy of trastuzumab beyond progression in HER2 positive advanced gastric cancer: a multicenter prospective observational cohort study
46
Citations
16
References
2016
Year
Continuing treatment of trastuzumab beyond first line therapy progression showed effective and safe in AGC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1